A Q&A with Jake Haling, Head of Oncology Drug Discovery in San Diego, on induced proximity and how it could open new paths to treat cancer.

While the country has made great strides in controlling AIDS and other infectious diseases, Kenyans are living longer and chronic diseases such as diabetes, heart disease and cancer are on the rise.

Alexandra Cossio Duque, a clinical and community research coordinator from Colombia, has travelled the world to study how to overcome social and geographic barriers to healthcare access. Today, she is working in her home country to strengthen the capacity of health systems to treat leishmaniasis, a neglected tropical disease that is endemic to rural areas of Colombia.

New NIBR President Jay Bradner shares on drug discovery, his leadership style and what’s next for his career in biomedical research.

Public health expert Richard Laing discusses how independent measurement of access programs can help ensure their success

The Chief Information Officer of the Novartis Institutes for BioMedical Research discusses his new role.

Three-dimensional clusters of human neurons could allow scientists to watch neurological diseases develop in the lab.

At Novartis, we are constantly pushing the limits of science to develop and deliver transformative medicines that fight disease and help people live life on their terms. 

A lung cancer researcher describes her journey toward a career in science at Novartis.

Radioligand therapy (RLT) has helped change what’s possible in prostate cancer treatment, but Novartis continues to work on the next wave of innovations to bring new options to patients.